A carregar...
Varenicline Augmentation in Depressed Smokers: An 8-week, Open-Label Study
OBJECTIVE: To assess possible antidepressant effects of varenicline augmentation in outpatients with treatment-resistant depressive disorders and nicotine dependence. BACKGROUND: Varenicline (Chantix) is a nicotinic acetylcholine receptor α4β2 partial agonist and α7 full agonist approved for smoking...
Na minha lista:
| Publicado no: | J Clin Psychiatry |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915480/ https://ncbi.nlm.nih.gov/pubmed/19323966 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|